Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's disease
W. J. Sandborn, J. F. Colombel, G. D'Haens, S. E. Plevy, J. Panés, A. M. Robinson, P. F. Pollack, Q. Zhou, M. Castillo, R. B. Thakkar
Research output: Contribution to journal › Article › peer-review
20Scopus
citations
Fingerprint
Dive into the research topics of 'Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's disease'. Together they form a unique fingerprint.